Crawford Fund Management, LLC Novavax Inc Put Options Transaction History

Crawford Fund Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$10.71 - $17.11 $546,210 - $872,610	-51,000 Reduced 50.5%	50,000 $632 Million
Q2 2024 Aug 14, 2024	SELL	$3.89 - $20.97 $11,670 - $62,910	-3,000 Reduced 2.88%	101,000 $1.28 Billion
Q1 2024 May 15, 2024	BUY	$3.76 - $6.02 $364,720 - $583,940	97,000 Added 1385.71%	104,000 $497 Million
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $33,600 - $53,690	7,000 New	7,000 $33.6 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $684M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Crawford Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Crawford Fund Management, LLC with notifications on news.